This comprehensive feature written by Daryl C. Donatelli, MBA, President, U.S. & Head of Global Marketing, Mauna Kea Technologies explores the Cellvizio platform and details how the technology is transforming cancer detection and treatment across gastroenterology and pulmonology, offering physicians unprecedented accuracy in diagnosing pancreatic cysts, Barrett’s esophagus, and lung lesions. The article highlights how real-time cellular visualization enables earlier detection, reduces the need for repeat procedures, and helps physicians make more confident treatment decisions, ultimately leading to improved patient outcomes and reduced healthcare costs.
